Evolution of Influenza A Virus by Mutation and Re-Assortment

Influenza A virus (IAV), a highly infectious respiratory pathogen, has continued to be a significant threat to global public health. To complete their life cycle, influenza viruses have evolved multiple strategies to interact with a host. A large number of studies have revealed that the evolution of...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 18; no. 8; p. 1650
Main Authors Shao, Wenhan, Li, Xinxin, Goraya, Mohsan, Wang, Song, Chen, Ji-Long
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 07.08.2017
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Influenza A virus (IAV), a highly infectious respiratory pathogen, has continued to be a significant threat to global public health. To complete their life cycle, influenza viruses have evolved multiple strategies to interact with a host. A large number of studies have revealed that the evolution of influenza A virus is mainly mediated through the mutation of the virus itself and the re-assortment of viral genomes derived from various strains. The evolution of influenza A virus through these mechanisms causes worldwide annual epidemics and occasional pandemics. Importantly, influenza A virus can evolve from an animal infected pathogen to a human infected pathogen. The highly pathogenic influenza virus has resulted in stupendous economic losses due to its morbidity and mortality both in human and animals. Influenza viruses fall into a category of viruses that can cause zoonotic infection with stable adaptation to human, leading to sustained horizontal transmission. The rapid mutations of influenza A virus result in the loss of vaccine optimal efficacy, and challenge the complete eradication of the virus. In this review, we highlight the current understanding of influenza A virus evolution caused by the mutation and re-assortment of viral genomes. In addition, we discuss the specific mechanisms by which the virus evolves.
AbstractList Influenza A virus (IAV), a highly infectious respiratory pathogen, has continued to be a significant threat to global public health. To complete their life cycle, influenza viruses have evolved multiple strategies to interact with a host. A large number of studies have revealed that the evolution of influenza A virus is mainly mediated through the mutation of the virus itself and the re-assortment of viral genomes derived from various strains. The evolution of influenza A virus through these mechanisms causes worldwide annual epidemics and occasional pandemics. Importantly, influenza A virus can evolve from an animal infected pathogen to a human infected pathogen. The highly pathogenic influenza virus has resulted in stupendous economic losses due to its morbidity and mortality both in human and animals. Influenza viruses fall into a category of viruses that can cause zoonotic infection with stable adaptation to human, leading to sustained horizontal transmission. The rapid mutations of influenza A virus result in the loss of vaccine optimal efficacy, and challenge the complete eradication of the virus. In this review, we highlight the current understanding of influenza A virus evolution caused by the mutation and re-assortment of viral genomes. In addition, we discuss the specific mechanisms by which the virus evolves.
Influenza A virus (IAV), a highly infectious respiratory pathogen, has continued to be a significant threat to global public health. To complete their life cycle, influenza viruses have evolved multiple strategies to interact with a host. A large number of studies have revealed that the evolution of influenza A virus is mainly mediated through the mutation of the virus itself and the re-assortment of viral genomes derived from various strains. The evolution of influenza A virus through these mechanisms causes worldwide annual epidemics and occasional pandemics. Importantly, influenza A virus can evolve from an animal infected pathogen to a human infected pathogen. The highly pathogenic influenza virus has resulted in stupendous economic losses due to its morbidity and mortality both in human and animals. Influenza viruses fall into a category of viruses that can cause zoonotic infection with stable adaptation to human, leading to sustained horizontal transmission. The rapid mutations of influenza A virus result in the loss of vaccine optimal efficacy, and challenge the complete eradication of the virus. In this review, we highlight the current understanding of influenza A virus evolution caused by the mutation and re-assortment of viral genomes. In addition, we discuss the specific mechanisms by which the virus evolves.Influenza A virus (IAV), a highly infectious respiratory pathogen, has continued to be a significant threat to global public health. To complete their life cycle, influenza viruses have evolved multiple strategies to interact with a host. A large number of studies have revealed that the evolution of influenza A virus is mainly mediated through the mutation of the virus itself and the re-assortment of viral genomes derived from various strains. The evolution of influenza A virus through these mechanisms causes worldwide annual epidemics and occasional pandemics. Importantly, influenza A virus can evolve from an animal infected pathogen to a human infected pathogen. The highly pathogenic influenza virus has resulted in stupendous economic losses due to its morbidity and mortality both in human and animals. Influenza viruses fall into a category of viruses that can cause zoonotic infection with stable adaptation to human, leading to sustained horizontal transmission. The rapid mutations of influenza A virus result in the loss of vaccine optimal efficacy, and challenge the complete eradication of the virus. In this review, we highlight the current understanding of influenza A virus evolution caused by the mutation and re-assortment of viral genomes. In addition, we discuss the specific mechanisms by which the virus evolves.
Author Shao, Wenhan
Chen, Ji-Long
Li, Xinxin
Wang, Song
Goraya, Mohsan
AuthorAffiliation 2 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
1 Key Laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China; ssjwen@outlook.com (W.S.); xinxinlfjfz@163.com (X.L.); goraya_uaf@yahoo.com (M.U.G.)
AuthorAffiliation_xml – name: 1 Key Laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China; ssjwen@outlook.com (W.S.); xinxinlfjfz@163.com (X.L.); goraya_uaf@yahoo.com (M.U.G.)
– name: 2 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
Author_xml – sequence: 1
  givenname: Wenhan
  surname: Shao
  fullname: Shao, Wenhan
– sequence: 2
  givenname: Xinxin
  surname: Li
  fullname: Li, Xinxin
– sequence: 3
  givenname: Mohsan
  orcidid: 0000-0001-6501-0662
  surname: Goraya
  fullname: Goraya, Mohsan
– sequence: 4
  givenname: Song
  surname: Wang
  fullname: Wang, Song
– sequence: 5
  givenname: Ji-Long
  surname: Chen
  fullname: Chen, Ji-Long
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28783091$$D View this record in MEDLINE/PubMed
BookMark eNpt0UtLxDAQAOAgirrqzbMUvHiwOnm0TUCERXwsKIKo15BmU83SJpq0gv56o6uyiqcE8s1kHiO07LwzCG1jOKBUwKGddRFz4LgsYAmtY0ZIDlBWywv3NTSKcQZAKCnEKlojvOIUBF5HR6cvvh16613mm2zimnYw7k1l4-zehiFm9Wt2NfTqEyg3zW5MPo7Rh74zrt9EK41qo9n6OjfQ3dnp7clFfnl9PjkZX-aaVbzPG4pLTEShysrUuigZ4KaYshoqLjSjZqqoIEYQDMzUDUCjDRVMQC00rozAdAMdz_M-DXVnpjp9HVQrn4LtVHiVXln5-8XZR_ngX2RRVBwYpAR7XwmCfx5M7GVnozZtq5zxQ5RYkFJwIJgluvuHzvwQXGovKSo4Y6KsktpZrOinlO_BJrA_Bzr4GINpfggG-bE3ubi3xMkfru186qkf2_4f9A4bM5po
CitedBy_id crossref_primary_10_1016_j_regg_2018_06_004
crossref_primary_10_3390_vaccines13030331
crossref_primary_10_3389_fmicb_2020_01912
crossref_primary_10_3390_molecules28010041
crossref_primary_10_1080_14786419_2019_1696791
crossref_primary_10_3390_ijerph22030400
crossref_primary_10_3390_v16030331
crossref_primary_10_1002_cti2_1491
crossref_primary_10_36016_JVMBBS_2023_9_3_6
crossref_primary_10_3390_ijms232012244
crossref_primary_10_1111_irv_70028
crossref_primary_10_3390_microbiolres14020045
crossref_primary_10_1016_j_virusres_2022_199033
crossref_primary_10_1016_j_virusres_2020_198061
crossref_primary_10_1016_j_talanta_2023_124855
crossref_primary_10_3390_molecules26040880
crossref_primary_10_1016_j_antiviral_2024_105925
crossref_primary_10_3390_vaccines12111220
crossref_primary_10_1002_jmv_26449
crossref_primary_10_1002_jmv_25913
crossref_primary_10_1002_jmv_27662
crossref_primary_10_1109_JSEN_2024_3388460
crossref_primary_10_3390_molecules27238313
crossref_primary_10_1021_acsnano_3c07669
crossref_primary_10_1111_tbed_14110
crossref_primary_10_3390_v16101638
crossref_primary_10_1038_s41598_018_36426_9
crossref_primary_10_3390_v16101515
crossref_primary_10_1111_tbed_13944
crossref_primary_10_3389_fanim_2024_1359681
crossref_primary_10_12688_f1000research_150975_3
crossref_primary_10_3390_cells8030228
crossref_primary_10_12688_f1000research_150975_2
crossref_primary_10_1637_aviandiseases_D_21_00075
crossref_primary_10_12688_f1000research_150975_1
crossref_primary_10_1128_mbio_01804_24
crossref_primary_10_1007_s42770_021_00550_y
crossref_primary_10_1186_s12879_021_07021_7
crossref_primary_10_3390_v14061312
crossref_primary_10_3389_fmicb_2021_747458
crossref_primary_10_3390_life12020156
crossref_primary_10_3389_fvets_2018_00347
crossref_primary_10_1093_bib_bbac362
crossref_primary_10_1016_j_jinf_2018_10_012
crossref_primary_10_1080_07391102_2022_2108901
crossref_primary_10_1007_s13337_018_0474_0
crossref_primary_10_1016_j_gene_2018_06_070
crossref_primary_10_1186_s12985_018_0971_1
crossref_primary_10_3390_v16121818
crossref_primary_10_1186_s12865_023_00573_0
crossref_primary_10_1128_CMR_00224_20
crossref_primary_10_3390_biom13010169
crossref_primary_10_1021_acsami_9b21776
crossref_primary_10_1186_s13104_025_07143_0
crossref_primary_10_3389_fphar_2022_899181
crossref_primary_10_3390_vaccines11071269
crossref_primary_10_3390_ijms22116031
crossref_primary_10_1186_s12953_023_00205_w
crossref_primary_10_3345_cep_2020_00759
crossref_primary_10_1016_j_biochi_2023_07_019
crossref_primary_10_1021_acssynbio_3c00526
crossref_primary_10_3390_ijms24087248
crossref_primary_10_1007_s00216_024_05256_2
crossref_primary_10_3390_vaccines8030449
crossref_primary_10_3934_mbe_2022482
crossref_primary_10_1186_s12985_023_02163_3
crossref_primary_10_7759_cureus_56715
crossref_primary_10_3390_tropicalmed8060326
crossref_primary_10_1016_j_virol_2021_06_001
crossref_primary_10_1088_1748_605X_aceceb
crossref_primary_10_1007_s00705_020_04624_4
crossref_primary_10_1016_j_bbrc_2021_01_058
crossref_primary_10_36233_0507_4088_257
crossref_primary_10_3390_v12091046
crossref_primary_10_3390_v13112165
crossref_primary_10_3390_vaccines9060657
crossref_primary_10_1021_acs_jmedchem_8b01683
crossref_primary_10_1007_s11033_022_07957_2
crossref_primary_10_1007_s00018_023_04764_1
crossref_primary_10_3389_fimmu_2025_1550968
crossref_primary_10_1080_21645515_2018_1462639
crossref_primary_10_3389_fmicb_2023_1267078
crossref_primary_10_3389_fmicb_2019_00738
crossref_primary_10_22207_JPAM_17_4_52
crossref_primary_10_1128_MRA_01274_20
crossref_primary_10_1007_s10989_021_10278_w
crossref_primary_10_3389_fmicb_2024_1392607
crossref_primary_10_3390_v14040825
crossref_primary_10_1016_j_psj_2019_11_053
crossref_primary_10_1016_j_antiviral_2023_105780
crossref_primary_10_3389_fvets_2023_1258269
crossref_primary_10_3390_bios11030066
crossref_primary_10_3390_ijms241210056
crossref_primary_10_1016_j_ejmech_2023_115678
crossref_primary_10_1016_j_nmni_2021_100873
crossref_primary_10_3389_fimmu_2021_707339
crossref_primary_10_1016_S2214_109X_23_00154_7
crossref_primary_10_1016_j_bsheal_2021_12_002
crossref_primary_10_1016_j_jiph_2024_102595
crossref_primary_10_1016_j_tmaid_2023_102638
crossref_primary_10_1007_s42247_021_00178_6
crossref_primary_10_3389_fimmu_2018_02017
crossref_primary_10_1002_jrs_6204
crossref_primary_10_1016_j_rinp_2021_104079
crossref_primary_10_1016_j_virusres_2022_198745
crossref_primary_10_1038_s43588_021_00136_6
crossref_primary_10_1016_j_jcpa_2024_06_001
crossref_primary_10_1002_mma_10680
crossref_primary_10_1371_journal_pone_0291900
crossref_primary_10_5808_gi_21077
crossref_primary_10_1002_bab_2540
crossref_primary_10_22625_2072_6732_2023_15_4_14_24
crossref_primary_10_1080_07391102_2023_2214228
crossref_primary_10_3390_vaccines8030488
crossref_primary_10_1016_j_psj_2024_104639
crossref_primary_10_59324_ejtas_2024_2_5__69
crossref_primary_10_3390_v14010094
crossref_primary_10_1111_irv_13252
crossref_primary_10_1080_07391102_2024_2305313
crossref_primary_10_3389_fcimb_2023_1258321
crossref_primary_10_3389_fmicb_2024_1435384
crossref_primary_10_1016_j_virs_2022_10_005
crossref_primary_10_3390_v17020225
crossref_primary_10_3389_fmicb_2020_01990
crossref_primary_10_1039_D4TB00742E
crossref_primary_10_12968_pnur_2024_35_4_118
crossref_primary_10_1016_j_jmgm_2025_108983
crossref_primary_10_3201_eid2912_230330
crossref_primary_10_3390_v11100912
crossref_primary_10_1128_spectrum_00665_24
crossref_primary_10_3390_molecules28145398
crossref_primary_10_1016_j_virs_2024_02_002
crossref_primary_10_47027_duvetfd_827886
crossref_primary_10_7883_yoken_JJID_2021_745
crossref_primary_10_1016_j_wroa_2023_100210
crossref_primary_10_3390_molecules28041981
crossref_primary_10_3390_v14092008
crossref_primary_10_3389_fimmu_2024_1432743
crossref_primary_10_1371_journal_pone_0289906
crossref_primary_10_3390_ijms23052452
crossref_primary_10_1002_rmv_2411
crossref_primary_10_1038_s41598_023_37122_z
crossref_primary_10_1080_14737159_2022_2116276
crossref_primary_10_1099_jgv_0_001985
crossref_primary_10_3390_v15091906
crossref_primary_10_1093_femsre_fuz019
crossref_primary_10_1038_s41598_024_80457_4
crossref_primary_10_3390_ijms242417386
crossref_primary_10_3390_microorganisms7060156
crossref_primary_10_1371_journal_pone_0229601
crossref_primary_10_15302_J_FASE_2021397
crossref_primary_10_1186_s42269_023_01101_1
crossref_primary_10_28982_josam_437319
crossref_primary_10_1155_2023_8339427
crossref_primary_10_1155_2023_2291051
crossref_primary_10_3389_fpubh_2024_1464435
crossref_primary_10_1016_j_lfs_2021_119652
crossref_primary_10_3389_fvets_2022_933274
crossref_primary_10_1080_20477724_2024_2323843
crossref_primary_10_4142_jvs_19411
crossref_primary_10_3390_scipharm91020028
crossref_primary_10_1111_tbed_13991
crossref_primary_10_1002_ptr_7039
crossref_primary_10_4142_jvs_2020_21_e66
crossref_primary_10_1039_D0CS01084G
crossref_primary_10_3390_vaccines10081359
crossref_primary_10_1016_j_chaos_2022_112823
crossref_primary_10_3390_md20050281
crossref_primary_10_3390_vaccines10081355
crossref_primary_10_2174_1389557522666220218122744
crossref_primary_10_1007_s11262_022_01935_3
crossref_primary_10_3389_abp_2024_12289
crossref_primary_10_1007_s00705_020_04869_z
crossref_primary_10_3389_fcimb_2023_1111143
crossref_primary_10_1002_jmv_26990
crossref_primary_10_3389_fimmu_2019_01457
crossref_primary_10_3389_fvets_2024_1439354
crossref_primary_10_3390_v15010200
crossref_primary_10_1038_s41598_021_87845_0
crossref_primary_10_1016_j_virol_2024_110167
crossref_primary_10_25259_SRJHS_16_2021
crossref_primary_10_1038_s41598_021_81558_0
crossref_primary_10_3389_fmicb_2024_1467029
crossref_primary_10_1016_j_chaos_2023_114106
crossref_primary_10_1016_j_vetmic_2025_110444
crossref_primary_10_7759_cureus_30062
crossref_primary_10_1007_s00203_020_02041_4
crossref_primary_10_3390_vaccines9020075
crossref_primary_10_1016_j_vaccine_2023_03_049
crossref_primary_10_3389_fviro_2023_1042724
crossref_primary_10_1016_j_ijid_2022_05_032
crossref_primary_10_3389_fmicb_2020_583588
crossref_primary_10_1002_advs_202105868
crossref_primary_10_3390_ijms23073634
crossref_primary_10_1080_21645515_2024_2435644
crossref_primary_10_1186_s42826_023_00177_0
crossref_primary_10_12968_pnur_2024_35_Sup12_11
crossref_primary_10_1016_j_antiviral_2025_106149
crossref_primary_10_1111_jcmm_15200
crossref_primary_10_3390_v13102087
crossref_primary_10_1002_jmv_27980
crossref_primary_10_1016_j_vaccine_2024_126638
crossref_primary_10_3390_ijms21186828
crossref_primary_10_1038_s41598_023_38128_3
crossref_primary_10_3390_ph16030365
crossref_primary_10_3390_v14102277
crossref_primary_10_1080_21505594_2020_1836904
crossref_primary_10_1088_1742_5468_ab74c6
crossref_primary_10_3390_v16071147
crossref_primary_10_4236_jamp_2022_1012248
crossref_primary_10_1038_s41598_020_79590_7
crossref_primary_10_3390_pathogens10030368
crossref_primary_10_1186_s12879_021_06510_z
crossref_primary_10_1016_j_chaos_2022_112909
crossref_primary_10_1016_j_virusres_2021_198625
crossref_primary_10_3390_ijms231911131
crossref_primary_10_3934_bdia_2025001
crossref_primary_10_3390_ani14071105
crossref_primary_10_3390_pathogens8040224
crossref_primary_10_1080_14760584_2020_1709827
crossref_primary_10_3390_v13061145
crossref_primary_10_1111_zph_12559
crossref_primary_10_1080_21505594_2022_2082672
crossref_primary_10_3390_v16111656
crossref_primary_10_3390_pathogens9121020
crossref_primary_10_3390_vaccines11111628
crossref_primary_10_3390_v14092074
crossref_primary_10_3390_v16091405
crossref_primary_10_1016_j_micpath_2019_103919
crossref_primary_10_1016_j_prevetmed_2024_106117
crossref_primary_10_1096_fj_202200473R
crossref_primary_10_1016_j_crmicr_2023_100202
crossref_primary_10_1016_j_prevetmed_2024_106351
crossref_primary_10_1016_j_colsurfb_2024_114385
crossref_primary_10_3390_ijerph192316289
crossref_primary_10_3390_vaccines12091033
crossref_primary_10_1007_s00705_024_06189_y
crossref_primary_10_2478_ii_2018_0023
crossref_primary_10_3390_ijerph17093092
crossref_primary_10_1016_S2095_3119_21_63840_6
crossref_primary_10_1155_2024_6661672
crossref_primary_10_1016_j_virol_2024_110246
Cites_doi 10.1016/j.ejphar.2017.05.038
10.3810/pgm.2009.09.2051
10.1002/embj.201387442
10.1073/pnas.0911915106
10.1371/journal.ppat.1001034
10.3389/fmicb.2013.00151
10.1038/nrd2175
10.3201/eid2006.140233
10.1093/molbev/msl102
10.1016/j.jfma.2017.02.011
10.1093/infdis/jir352
10.1128/JVI.02439-15
10.1098/rstb.2001.0998
10.1073/pnas.0807142105
10.1016/j.virol.2008.07.014
10.2147/IDR.S105473
10.1016/0092-8674(81)90208-7
10.1016/j.vaccine.2009.01.016
10.3201/eid2004.131295
10.1016/j.virusres.2004.02.034
10.1128/JVI.03052-15
10.1099/vir.0.041228-0
10.1371/journal.ppat.1003657
10.3201/eid2304.161866
10.1046/j.1365-2672.2001.01492.x
10.1038/srep23746
10.1016/j.virusres.2006.09.013
10.3201/eid2302.161252
10.1146/annurev.med.51.1.407
10.1016/S0092-8674(00)81771-7
10.1128/JVI.01785-09
10.1038/nrmicro2613
10.1007/s10822-016-9981-5
10.1186/1471-2334-14-480
10.1038/srep33334
10.1017/S1466252307001272
10.1016/j.cmi.2016.07.007
10.1016/j.micinf.2005.12.008
10.1006/viro.1993.1155
10.1056/NEJMra1002842
10.1056/NEJMp0904572
10.1016/0042-6822(91)90588-3
10.1371/journal.ppat.1005583
10.1099/vir.0.19302-0
10.1016/S0140-6736(03)14854-4
10.1128/JVI.01175-13
10.1038/srep26787
10.1002/wrna.1321
10.1038/s41598-017-02598-z
10.1128/jvi.69.2.1099-1106.1995
10.1016/j.antiviral.2016.01.012
10.1007/s13238-015-0191-z
10.1038/nature14348
10.1146/annurev-immunol-032713-120231
10.1016/S0140-6736(14)60111-2
10.1038/nri3665
10.1111/nyas.12462
10.4049/jimmunol.0804198
10.1126/science.1236787
10.1056/NEJMoa1304459
10.20506/rst.28.1.1879
10.1086/502973
10.1371/journal.pone.0046183
10.1038/nature12372
10.1371/journal.ppat.1003845
10.1016/j.jinf.2011.04.013
10.1371/journal.ppat.1006390
10.1016/S0753-3322(00)89026-5
10.1017/S1466252310000071
10.1016/S1473-3099(17)30323-7
10.1056/NEJMoa0903810
10.1586/14760584.2013.824709
10.1016/j.ijid.2016.01.002
10.1126/science.1242917
10.3201/eid2308.170143
10.1128/JVI.06203-11
10.1016/j.vaccine.2007.07.027
10.3390/v4091438
10.1038/srep43566
10.1038/nsmb.1909
10.1016/S0753-3322(00)89025-3
10.1016/j.chom.2010.05.009
10.1006/viro.1994.1555
10.3201/eid1004.030396
10.1038/nature06945
10.1126/science.1069132
10.1007/s11427-009-0062-z
10.1038/srep03058
10.1016/j.vaccine.2007.08.042
10.1128/JVI.00126-14
10.1038/nature03063
10.1099/vir.0.19277-0
10.1126/science.1222213
10.1098/rstb.2001.0999
10.1099/vir.0.82120-0
10.3390/v5102424
10.1016/S0140-6736(13)60903-4
10.3389/fmicb.2017.00741
10.1186/s13567-017-0435-4
ContentType Journal Article
Copyright Copyright MDPI AG 2017
2017 by the authors. 2017
Copyright_xml – notice: Copyright MDPI AG 2017
– notice: 2017 by the authors. 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOI 10.3390/ijms18081650
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

Publicly Available Content Database
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID PMC5578040
28783091
10_3390_ijms18081650
Genre Journal Article
Review
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
IPNFZ
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
3V.
ABJCF
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c478t-f3161295a67ebc56401f5d4b0789c43eda392e92104ebf00fce39490b9c17e913
IEDL.DBID M48
ISSN 1422-0067
1661-6596
IngestDate Thu Aug 21 17:53:35 EDT 2025
Fri Jul 11 14:12:11 EDT 2025
Fri Jul 25 20:35:06 EDT 2025
Wed Feb 19 02:41:30 EST 2025
Tue Jul 01 03:30:03 EDT 2025
Thu Apr 24 23:04:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords virus-host interaction
mutation
re-assortment
influenza A virus
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c478t-f3161295a67ebc56401f5d4b0789c43eda392e92104ebf00fce39490b9c17e913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-6501-0662
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms18081650
PMID 28783091
PQID 1939844967
PQPubID 2032341
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5578040
proquest_miscellaneous_1926980214
proquest_journals_1939844967
pubmed_primary_28783091
crossref_primary_10_3390_ijms18081650
crossref_citationtrail_10_3390_ijms18081650
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-08-07
PublicationDateYYYYMMDD 2017-08-07
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-07
  day: 07
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2017
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_93
Li (ref_63) 2017; 7
Li (ref_77) 2017; 23
Fan (ref_54) 2012; 93
Barman (ref_76) 2017; 23
Yoon (ref_88) 2014; 385
Chen (ref_92) 2013; 381
Iwasaki (ref_32) 2014; 14
Goraya (ref_36) 2015; 6
Yang (ref_65) 2017; 116
Rambaut (ref_90) 2008; 453
Potter (ref_7) 2001; 91
Brown (ref_20) 2000; 54
Dawood (ref_71) 2009; 360
Jhung (ref_78) 2015; 64
Carrat (ref_47) 2007; 25
Rimmelzwaan (ref_55) 2009; 27
Schneider (ref_33) 2014; 32
Webster (ref_102) 2014; 1323
Fouchier (ref_18) 2014; 33
Ma (ref_43) 2008; 3
Chare (ref_83) 2003; 84
Phanich (ref_52) 2016; 30
Mwangi (ref_105) 2016; 6
Gao (ref_61) 2013; 368
Shi (ref_94) 2013; 342
Wang (ref_104) 2016; 6
Chen (ref_19) 1998; 95
Mehle (ref_46) 2012; 86
Liu (ref_22) 1995; 69
Bertran (ref_79) 2017; 48
ref_74
Taubenberger (ref_44) 2010; 7
He (ref_84) 2008; 380
Schmolke (ref_37) 2009; 183
Wang (ref_35) 2014; 88
Ohuchi (ref_23) 2006; 8
Lee (ref_75) 2014; 20
Orlich (ref_81) 1994; 204
Taubenberger (ref_89) 2009; 28
Reid (ref_67) 2003; 84
Russell (ref_15) 2008; 105
Zhang (ref_41) 2013; 340
Peng (ref_9) 2017; 7
Forrest (ref_1) 2010; 11
Fischer (ref_97) 2017; 809
Kreijtz (ref_56) 2016; 90
Lee (ref_73) 2017; 23
Kreijtz (ref_58) 2012; 4
Li (ref_31) 2015; 43
Gong (ref_38) 2011; 204
Lam (ref_95) 2015; 522
ref_60
Ahlquist (ref_39) 2002; 296
Matsuzaki (ref_2) 2006; 193
Herz (ref_28) 1981; 26
McAuley (ref_66) 2010; 84
Kuszewski (ref_5) 2000; 54
Gaymard (ref_26) 2016; 22
Zaraket (ref_50) 2013; 87
ref_64
Hay (ref_3) 2001; 356
Dortmans (ref_48) 2013; 3
Hannoun (ref_98) 2013; 12
Kayali (ref_96) 2014; 20
Liu (ref_25) 2009; 52
Castrucci (ref_42) 1993; 193
Rubio (ref_85) 2013; 4
Hutchinson (ref_29) 2013; 5
Vergaraalert (ref_69) 2014; 45
Lambert (ref_99) 2010; 363
Li (ref_24) 2010; 17
Mehle (ref_59) 2009; 106
Scalera (ref_91) 2009; 121
Xiong (ref_49) 2013; 499
Medina (ref_14) 2011; 9
ref_34
Wu (ref_80) 2017; 8
Mills (ref_6) 2004; 432
Cox (ref_12) 2000; 51
Webster (ref_45) 1992; 56
(ref_68) 2006; 5
Chen (ref_40) 2006; 23
Tong (ref_16) 2013; 9
Chen (ref_86) 2016; 43
Schrauwen (ref_51) 2016; 90
Landolt (ref_70) 2007; 8
Couch (ref_100) 2007; 25
Berkhoff (ref_57) 2007; 88
Hussain (ref_101) 2017; 10
Potter (ref_4) 2011; 63
Nicholson (ref_17) 2003; 362
Trifonov (ref_72) 2009; 361
Ouyang (ref_30) 2016; 7
Woolthuis (ref_53) 2016; 6
Jagger (ref_11) 2012; 337
Boulo (ref_27) 2007; 124
Chen (ref_62) 2014; 383
ref_8
Aoyama (ref_13) 1991; 182
Suarez (ref_82) 2004; 10
Gibbs (ref_87) 2001; 356
Fry (ref_103) 2016; 129
Gubareva (ref_21) 2004; 103
Wang (ref_10) 2017; 17
14643124 - Lancet. 2003 Nov 22;362(9397):1733-45
17719149 - Vaccine. 2007 Sep 28;25(39-40):6852-62
19004788 - Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41
24009358 - Science. 2013 Oct 11;342(6155):243-7
26537686 - J Virol. 2015 Nov 04;90(2):1009-22
20700447 - PLoS Pathog. 2010 Aug 05;6(8):e1001034
24130481 - PLoS Pathog. 2013;9(10):e1003657
28583578 - Lancet Infect Dis. 2017 Aug;17 (8):822-832
8438586 - Virology. 1993 Mar;193(1):503-6
17251571 - J Gen Virol. 2007 Feb;88(Pt 2):530-5
17692139 - Anim Health Res Rev. 2007 Jun;8(1):1-21
28262734 - Sci Rep. 2017 Mar 06;7:43566
19618626 - Rev Sci Tech. 2009 Apr;28(1):187-202
12917448 - J Gen Virol. 2003 Sep;84(Pt 9):2285-92
19995968 - Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21312-6
28169827 - Emerg Infect Dis. 2017 Apr;23 (4):637-641
22090127 - J Virol. 2012 Feb;86(3):1750-7
25762140 - Nature. 2015 Jun 4;522(7554):102-5
7326745 - Cell. 1981 Nov;26(3 Pt 1):391-400
23641058 - Science. 2013 Jun 21;340(6139):1463-7
26792744 - J Virol. 2016 Jan 20;90(7):3794-9
21632115 - J Infect. 2011 Oct;63(4):252-9
23623390 - Lancet. 2013 Jun 1;381(9881):1916-25
10872717 - Biomed Pharmacother. 2000 May;54(4):188-95
19840674 - Vaccine. 2009 Oct 23;27(45):6363-5
26490959 - Nucleic Acids Res. 2015 Dec 2;43(21):10321-37
20852645 - Nat Struct Mol Biol. 2010 Oct;17(10):1266-8
24104053 - Viruses. 2013 Oct 02;5(10):2424-46
21083388 - N Engl J Med. 2010 Nov 18;363(21):2036-44
23824818 - J Virol. 2013 Sep;87(17):9911-22
20591210 - Anim Health Res Rev. 2010 Jun;11(1):3-18
10872718 - Biomed Pharmacother. 2000 May;54(4):196-209
24668228 - EMBO J. 2014 Apr 16;33(8):823-41
24391501 - PLoS Pathog. 2014 Jan;10 (1):e1003845
19786538 - J Immunol. 2009 Oct 15;183(8):5180-9
24507376 - Lancet. 2014 Feb 22;383(9918):714-21
8091680 - Virology. 1994 Oct;204(1):462-5
18721995 - Virology. 2008 Oct 10;380(1):12-20
28259506 - J Formos Med Assoc. 2017 Mar;116(3):210-212
19820273 - Postgrad Med. 2009 Sep;121(5):43-7
13679603 - J Gen Virol. 2003 Oct;84(Pt 10):2691-703
11779383 - Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1845-55
1579108 - Microbiol Rev. 1992 Mar;56(1):152-79
17913310 - Vaccine. 2007 Nov 1;25(44):7656-63
22302878 - J Gen Virol. 2012 May;93(Pt 5):987-97
27629812 - Sci Rep. 2016 Sep 15;6:33334
24655395 - Emerg Infect Dis. 2014 Apr;20(4):542-51
28539661 - Sci Rep. 2017 May 24;7(1):2352
28487690 - Front Microbiol. 2017 Apr 25;8:741
24829357 - J Virol. 2014 Aug;88(15):8375-85
28592320 - Vet Res. 2017 Jun 7;48(1):33
26206138 - Protein Cell. 2015 Oct;6(10):712-21
17139286 - Nat Rev Drug Discov. 2006 Dec;5(12):1015-25
28458567 - Infect Drug Resist. 2017 Apr 20;10 :121-134
24990620 - Curr Top Microbiol Immunol. 2014;385:359-75
21791661 - J Infect Dis. 2011 Aug 15;204(4):592-600
21747392 - Nat Rev Microbiol. 2011 Jul 11;9(8):590-603
24762827 - Nat Rev Immunol. 2014 May;14(5):315-28
26778522 - Int J Infect Dis. 2016 Feb;43:85-9
9814710 - Cell. 1998 Oct 30;95(3):409-17
16586359 - J Infect Dis. 2006 May 1;193(9):1229-35
27875109 - Emerg Infect Dis. 2017 Feb;23 (2):359-360
23787694 - Nature. 2013 Jul 25;499(7459):496-9
25654614 - MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):111
28533172 - Eur J Pharmacol. 2017 Aug 15;809:178-190
24024871 - Expert Rev Vaccines. 2013 Sep;12(9):1085-94
2024485 - Virology. 1991 Jun;182(2):475-85
17081640 - Virus Res. 2007 Mar;124(1-2):12-21
22745253 - Science. 2012 Jul 13;337(6091):199-204
20542248 - Cell Host Microbe. 2010 Jun 25;7(6):440-51
27097026 - PLoS Pathog. 2016 Apr 20;12(4):e1005583
18418375 - Nature. 2008 May 29;453(7195):615-9
19565018 - J Mol Genet Med. 2008 Nov 27;3(1):158-66
28609260 - Emerg Infect Dis. 2017 Aug;23 (8):1368-1371
16682242 - Microbes Infect. 2006 Apr;8(5):1287-93
26667656 - Wiley Interdiscip Rev RNA. 2016 Jan-Feb;7(1):129-43
24460592 - Vet Res. 2014 Jan 25;45:7
24555472 - Annu Rev Immunol. 2014;32:513-45
15602562 - Nature. 2004 Dec 16;432(7019):904-6
12016304 - Science. 2002 May 17;296(5571):1270-3
7815489 - J Virol. 1995 Feb;69(2):1099-106
11576290 - J Appl Microbiol. 2001 Oct;91(4):572-9
23577628 - N Engl J Med. 2013 May 16;368(20):1888-97
16945980 - Mol Biol Evol. 2006 Dec;23(12):2336-41
19423869 - N Engl J Med. 2009 Jun 18;360(25):2605-15
19474418 - N Engl J Med. 2009 Jul 9;361(2):115-9
25186370 - BMC Infect Dis. 2014 Sep 04;14:480
15163510 - Virus Res. 2004 Jul;103(1-2):199-203
19471865 - Sci China C Life Sci. 2009 May;52(5):428-38
23805130 - Front Microbiol. 2013 Jun 26;4:151
27279280 - Sci Rep. 2016 Jun 09;6:26787
15200862 - Emerg Infect Dis. 2004 Apr;10(4):693-9
27033724 - Sci Rep. 2016 Apr 01;6:23746
28617868 - PLoS Pathog. 2017 Jun 15;13(6):e1006390
24162312 - Sci Rep. 2013 Oct 28;3:3058
26872862 - Antiviral Res. 2016 May;129:21-38
23049973 - PLoS One. 2012;7(9):e46183
11779385 - Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1861-70
10774473 - Annu Rev Med. 2000;51:407-21
24891213 - Ann N Y Acad Sci. 2014 Sep;1323:115-39
27424943 - Clin Microbiol Infect. 2016 Dec;22(12 ):975-983
19828614 - J Virol. 2010 Jan;84(1):558-64
23170167 - Viruses. 2012 Sep;4(9):1438-76
24856098 - Emerg Infect Dis. 2014 Jun;20(6):1087-9
27714494 - J Comput Aided Mol Des. 2016 Oct;30(10 ):917-926
References_xml – volume: 809
  start-page: 178
  year: 2017
  ident: ref_97
  article-title: New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2017.05.038
– volume: 121
  start-page: 43
  year: 2009
  ident: ref_91
  article-title: The first pandemic of the 21st century: A review of the 2009 pandemic variant influenza A (H1N1) virus
  publication-title: Postgrad. Med.
  doi: 10.3810/pgm.2009.09.2051
– volume: 33
  start-page: 823
  year: 2014
  ident: ref_18
  article-title: Role of receptor binding specificity in influenza A virus transmission and pathogenesis
  publication-title: EMBO J.
  doi: 10.1002/embj.201387442
– volume: 106
  start-page: 21312
  year: 2009
  ident: ref_59
  article-title: Adaptive strategies of the influenza virus polymerase for replication in humans
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0911915106
– ident: ref_60
  doi: 10.1371/journal.ppat.1001034
– volume: 4
  start-page: 151
  year: 2013
  ident: ref_85
  article-title: Genetic variability and evolutionary dynamics of viruses of the family Closteroviridae
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2013.00151
– volume: 5
  start-page: 1015
  year: 2006
  ident: ref_68
  article-title: Antiviral agents active against influenza A viruses
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2175
– volume: 20
  start-page: 1087
  year: 2014
  ident: ref_75
  article-title: Novel reassortant influenza A(H5N8) viruses, South Korea, 2014
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2006.140233
– volume: 23
  start-page: 2336
  year: 2006
  ident: ref_40
  article-title: Avian influenza virus exhibits rapid evolutionary dynamics
  publication-title: Mol. Biol. Evol.
  doi: 10.1093/molbev/msl102
– volume: 116
  start-page: 210
  year: 2017
  ident: ref_65
  article-title: Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017
  publication-title: J. Formos. Med. Assoc.
  doi: 10.1016/j.jfma.2017.02.011
– volume: 204
  start-page: 592
  year: 2011
  ident: ref_38
  article-title: Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jir352
– volume: 90
  start-page: 1009
  year: 2016
  ident: ref_56
  article-title: Differential recognition of influenza A viruses by M1(58–66) epitope-specific CD8(+) T Cells is determined by extraepitopic amino acid residues
  publication-title: J. Virol.
  doi: 10.1128/JVI.02439-15
– volume: 356
  start-page: 1845
  year: 2001
  ident: ref_87
  article-title: The haemagglutinin gene, but not the neuraminidase gene, of 'Spanish flu' was a recombinant
  publication-title: Philos. Trans. R Soc. Lond. B Biol. Sci.
  doi: 10.1098/rstb.2001.0998
– volume: 105
  start-page: 17736
  year: 2008
  ident: ref_15
  article-title: Structure of influenza Hemagglutinin in complex with an inhibitor of membrane fusion
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0807142105
– volume: 380
  start-page: 12
  year: 2008
  ident: ref_84
  article-title: Homologous recombination evidence in human and swine influenza A viruses
  publication-title: Virology
  doi: 10.1016/j.virol.2008.07.014
– volume: 10
  start-page: 121
  year: 2017
  ident: ref_101
  article-title: Drug resistance in influenza A virus: The epidemiology and management
  publication-title: Infect. Drug Resist.
  doi: 10.2147/IDR.S105473
– volume: 26
  start-page: 391
  year: 1981
  ident: ref_28
  article-title: Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells
  publication-title: Cell
  doi: 10.1016/0092-8674(81)90208-7
– volume: 43
  start-page: 10321
  year: 2015
  ident: ref_31
  article-title: Robust expression of vault RNAs induced by influenza A virus plays a critical role in suppression of PKR-mediated innate immunity
  publication-title: Nucleic Acids Res.
– volume: 27
  start-page: 6363
  year: 2009
  ident: ref_55
  article-title: Influenza virus CTL epitopes, remarkably conserved and remarkably variable
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.01.016
– volume: 20
  start-page: 542
  year: 2014
  ident: ref_96
  article-title: Active surveillance for avian influenza virus, Egypt, 2010-2012
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2004.131295
– volume: 103
  start-page: 199
  year: 2004
  ident: ref_21
  article-title: Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
  publication-title: Virus. Res.
  doi: 10.1016/j.virusres.2004.02.034
– volume: 90
  start-page: 3794
  year: 2016
  ident: ref_51
  article-title: Amino acid substitutions that affect receptor binding and stability of the Hemagglutinin of influenza A/H7N9 virus
  publication-title: J. Virol.
  doi: 10.1128/JVI.03052-15
– volume: 93
  start-page: 987
  year: 2012
  ident: ref_54
  article-title: Role of Itk signalling in the interaction between influenza A virus and T-cells
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.041228-0
– volume: 9
  start-page: 1078
  year: 2013
  ident: ref_16
  article-title: New world bats harbor diverse influenza A viruses
  publication-title: PLoS Path.
  doi: 10.1371/journal.ppat.1003657
– volume: 56
  start-page: 152
  year: 1992
  ident: ref_45
  article-title: Evolution and ecology of influenza A viruses
  publication-title: Curr. Top Microbiol. Immunol.
– volume: 23
  start-page: 637
  year: 2017
  ident: ref_77
  article-title: Highly pathogenic avian influenza A(H5N8) virus in wild migratory birds, Qinghai Lake, China
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2304.161866
– volume: 91
  start-page: 572
  year: 2001
  ident: ref_7
  article-title: A history of influenza
  publication-title: J. Appl. Microbiol.
  doi: 10.1046/j.1365-2672.2001.01492.x
– volume: 6
  start-page: 23746
  year: 2016
  ident: ref_104
  article-title: Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome
  publication-title: Sci. Rep.
  doi: 10.1038/srep23746
– volume: 124
  start-page: 12
  year: 2007
  ident: ref_27
  article-title: Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes
  publication-title: Virus. Res.
  doi: 10.1016/j.virusres.2006.09.013
– volume: 23
  start-page: 359
  year: 2017
  ident: ref_73
  article-title: Novel reassortant clade 2.3.4.4 avian influenza A(H5N8) virus in wild aquatic birds, Russia, 2016
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2302.161252
– volume: 64
  start-page: 111
  year: 2015
  ident: ref_78
  article-title: Outbreaks of avian influenza A (H5N2), (H5N8), and (H5N1) among birds—United States, December 2014–January 2015
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
– volume: 51
  start-page: 407
  year: 2000
  ident: ref_12
  article-title: Global epidemiology of influenza: Past and present
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev.med.51.1.407
– volume: 45
  start-page: 1
  year: 2014
  ident: ref_69
  article-title: The NS segment of H5N1 avian influenza viruses (AIV) enhances the virulence of an H7N1 AIV in chickens
  publication-title: Vet. Res.
– volume: 95
  start-page: 409
  year: 1998
  ident: ref_19
  article-title: Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81771-7
– volume: 84
  start-page: 558
  year: 2010
  ident: ref_66
  article-title: The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis
  publication-title: J. Virol.
  doi: 10.1128/JVI.01785-09
– volume: 9
  start-page: 590
  year: 2011
  ident: ref_14
  article-title: Influenza A viruses: New research developments
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro2613
– volume: 30
  start-page: 917
  year: 2016
  ident: ref_52
  article-title: Role of R292K mutation in influenza H7N9 neuraminidase toward oseltamivir susceptibility: MD and MM/PB(GB)SA study
  publication-title: J. Comput. Aided Mol. Des.
  doi: 10.1007/s10822-016-9981-5
– ident: ref_8
  doi: 10.1186/1471-2334-14-480
– volume: 6
  start-page: 33334
  year: 2016
  ident: ref_53
  article-title: Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition
  publication-title: Sci. Rep.
  doi: 10.1038/srep33334
– volume: 8
  start-page: 1
  year: 2007
  ident: ref_70
  article-title: Up to new tricks—A review of cross-species transmission of influenza A viruses
  publication-title: Anim. Health Res. Rev.
  doi: 10.1017/S1466252307001272
– volume: 22
  start-page: 975
  year: 2016
  ident: ref_26
  article-title: Functional balance between neuraminidase and haemagglutinin in influenza viruses
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2016.07.007
– volume: 8
  start-page: 1287
  year: 2006
  ident: ref_23
  article-title: Roles of neuraminidase in the initial stage of influenza virus infection
  publication-title: Microbes. Infect.
  doi: 10.1016/j.micinf.2005.12.008
– volume: 193
  start-page: 503
  year: 1993
  ident: ref_42
  article-title: Genetic reassortment between avian and human influenza A viruses in Italian pigs
  publication-title: Virology
  doi: 10.1006/viro.1993.1155
– volume: 363
  start-page: 2036
  year: 2010
  ident: ref_99
  article-title: Influenza vaccines for the future
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1002842
– volume: 361
  start-page: 115
  year: 2009
  ident: ref_72
  article-title: Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp0904572
– volume: 182
  start-page: 475
  year: 1991
  ident: ref_13
  article-title: Comparison of complete amino acid sequences among 13 serotypes of Hemagglutinins and receptor-binding properties of influenza A viruses indirect immunofluorescence
  publication-title: Virology
  doi: 10.1016/0042-6822(91)90588-3
– ident: ref_64
  doi: 10.1371/journal.ppat.1005583
– volume: 84
  start-page: 2285
  year: 2003
  ident: ref_67
  article-title: the origin of the 1918 pandemic influenza virus: A continuing enigma
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.19302-0
– volume: 362
  start-page: 1733
  year: 2003
  ident: ref_17
  article-title: Influenza
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(03)14854-4
– volume: 87
  start-page: 9911
  year: 2013
  ident: ref_50
  article-title: Increased acid stability of the Hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets
  publication-title: J. Virol.
  doi: 10.1128/JVI.01175-13
– volume: 6
  start-page: 26787
  year: 2016
  ident: ref_105
  article-title: Host genetics determine susceptibility to avian influenza infection and transmission dynamics
  publication-title: Sci. Rep.
  doi: 10.1038/srep26787
– volume: 7
  start-page: 129
  year: 2016
  ident: ref_30
  article-title: lncRNAs regulate the innate immune response to viral infection
  publication-title: Wiley Interdiscip. Rev. RNA
  doi: 10.1002/wrna.1321
– volume: 7
  start-page: 2352
  year: 2017
  ident: ref_63
  article-title: The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-02598-z
– volume: 69
  start-page: 1099
  year: 1995
  ident: ref_22
  article-title: Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding
  publication-title: J. Virol.
  doi: 10.1128/jvi.69.2.1099-1106.1995
– volume: 129
  start-page: 21
  year: 2016
  ident: ref_103
  article-title: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses
  publication-title: Antiviral. Res.
  doi: 10.1016/j.antiviral.2016.01.012
– volume: 6
  start-page: 712
  year: 2015
  ident: ref_36
  article-title: Induction of innate immunity and its perturbation by influenza viruses
  publication-title: Protein Cell
  doi: 10.1007/s13238-015-0191-z
– volume: 522
  start-page: 102
  year: 2015
  ident: ref_95
  article-title: Dissemination, divergence and establishment of H7N9 influenza viruses in China
  publication-title: Nature
  doi: 10.1038/nature14348
– volume: 32
  start-page: 513
  year: 2014
  ident: ref_33
  article-title: Interferon-stimulated genes: A complex web of host defenses
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-032713-120231
– volume: 385
  start-page: 359
  year: 2014
  ident: ref_88
  article-title: Evolution and ecology of influenza A viruses
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 383
  start-page: 714
  year: 2014
  ident: ref_62
  article-title: Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: A descriptive study
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(14)60111-2
– volume: 14
  start-page: 315
  year: 2014
  ident: ref_32
  article-title: Innate immunity to influenza virus infection
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3665
– volume: 1323
  start-page: 115
  year: 2014
  ident: ref_102
  article-title: Continuing challenges in influenza
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.12462
– volume: 183
  start-page: 5180
  year: 2009
  ident: ref_37
  article-title: Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0804198
– volume: 340
  start-page: 1463
  year: 2013
  ident: ref_41
  article-title: An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level
  publication-title: Science
  doi: 10.1126/science.1236787
– volume: 368
  start-page: 1888
  year: 2013
  ident: ref_61
  article-title: Human infection with a novel avian-origin influenza A (H7N9) virus
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1304459
– volume: 28
  start-page: 187
  year: 2009
  ident: ref_89
  article-title: Pandemic influenza—Including a risk assessment of H5N1
  publication-title: Rev. Sci. Tech.
  doi: 10.20506/rst.28.1.1879
– volume: 193
  start-page: 1229
  year: 2006
  ident: ref_2
  article-title: Clinical features of influenza C virus infection in children
  publication-title: J. Infect. Dis.
  doi: 10.1086/502973
– ident: ref_74
  doi: 10.1371/journal.pone.0046183
– volume: 499
  start-page: 496
  year: 2013
  ident: ref_49
  article-title: Receptor binding by an H7N9 influenza virus from humans
  publication-title: Nature
  doi: 10.1038/nature12372
– ident: ref_34
  doi: 10.1371/journal.ppat.1003845
– volume: 63
  start-page: 252
  year: 2011
  ident: ref_4
  article-title: A definition for influenza pandemics based on historical records
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2011.04.013
– ident: ref_93
  doi: 10.1371/journal.ppat.1006390
– volume: 54
  start-page: 196
  year: 2000
  ident: ref_20
  article-title: Influenza virus genetics
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/S0753-3322(00)89026-5
– volume: 11
  start-page: 3
  year: 2010
  ident: ref_1
  article-title: Perspectives on influenza evolution and the role of research
  publication-title: Anim. Health Res. Rev.
  doi: 10.1017/S1466252310000071
– volume: 17
  start-page: 822
  year: 2017
  ident: ref_10
  article-title: Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: An epidemiological study of laboratory-confirmed case series
  publication-title: Lancet. Infect. Dis.
  doi: 10.1016/S1473-3099(17)30323-7
– volume: 360
  start-page: 2605
  year: 2009
  ident: ref_71
  article-title: Emergence of a novel swine-origin influenza A (H1N1) virus in humans
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0903810
– volume: 12
  start-page: 1085
  year: 2013
  ident: ref_98
  article-title: The evolving history of influenza viruses and influenza vaccines
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/14760584.2013.824709
– volume: 43
  start-page: 85
  year: 2016
  ident: ref_86
  article-title: Is a highly pathogenic avian influenza virus H5N1 fragment recombined in PB1 the key for the epidemic of the novel AIV H7N9 in China, 2013?
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2016.01.002
– volume: 342
  start-page: 243
  year: 2013
  ident: ref_94
  article-title: Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses
  publication-title: Science
  doi: 10.1126/science.1242917
– volume: 23
  start-page: 1368
  year: 2017
  ident: ref_76
  article-title: Genesis of influenza A(H5N8) viruses
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2308.170143
– volume: 86
  start-page: 1750
  year: 2012
  ident: ref_46
  article-title: Reassortment and mutation of the avian influenza virus polymerase PA Subunit overcome species barriers
  publication-title: J. Virol.
  doi: 10.1128/JVI.06203-11
– volume: 25
  start-page: 6852
  year: 2007
  ident: ref_47
  article-title: Influenza vaccine: The challenge of antigenic drift
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.07.027
– volume: 4
  start-page: 1438
  year: 2012
  ident: ref_58
  article-title: Evasion of influenza A viruses from innate and adaptive immune responses
  publication-title: Viruses
  doi: 10.3390/v4091438
– volume: 7
  start-page: 43566
  year: 2017
  ident: ref_9
  article-title: Continual antigenic diversification in China leads to global antigenic complexity of avian influenza H5N1 viruses
  publication-title: Sci. Rep.
  doi: 10.1038/srep43566
– volume: 17
  start-page: 1266
  year: 2010
  ident: ref_24
  article-title: The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb.1909
– volume: 54
  start-page: 188
  year: 2000
  ident: ref_5
  article-title: The epidemiology and history of influenza
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/S0753-3322(00)89025-3
– volume: 7
  start-page: 440
  year: 2010
  ident: ref_44
  article-title: Influenza virus evolution, host adaptation, and pandemic formation
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2010.05.009
– volume: 204
  start-page: 462
  year: 1994
  ident: ref_81
  article-title: Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus
  publication-title: Virology
  doi: 10.1006/viro.1994.1555
– volume: 10
  start-page: 693
  year: 2004
  ident: ref_82
  article-title: Recombination resulting in virulence shift in avian influenza outbreak, Chile
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid1004.030396
– volume: 453
  start-page: 615
  year: 2008
  ident: ref_90
  article-title: The genomic and epidemiological dynamics of human influenza A virus
  publication-title: Nature
  doi: 10.1038/nature06945
– volume: 296
  start-page: 1270
  year: 2002
  ident: ref_39
  article-title: RNA-dependent RNA polymerases, viruses, and RNA silencing
  publication-title: Science
  doi: 10.1126/science.1069132
– volume: 52
  start-page: 428
  year: 2009
  ident: ref_25
  article-title: Interspecies transmission and host restriction of avian H5N1 influenza virus
  publication-title: Sci. China C Life Sci.
  doi: 10.1007/s11427-009-0062-z
– volume: 3
  start-page: 3058
  year: 2013
  ident: ref_48
  article-title: Adaptation of novel H7N9 influenza A virus to human receptors
  publication-title: Sci. Rep.
  doi: 10.1038/srep03058
– volume: 3
  start-page: 158
  year: 2008
  ident: ref_43
  article-title: The pig as a mixing vessel for influenza viruses: Human and veterinary implications
  publication-title: J. Mol. Genet. Med.
– volume: 25
  start-page: 7656
  year: 2007
  ident: ref_100
  article-title: Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.08.042
– volume: 88
  start-page: 8375
  year: 2014
  ident: ref_35
  article-title: Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression
  publication-title: J. Virol.
  doi: 10.1128/JVI.00126-14
– volume: 432
  start-page: 904
  year: 2004
  ident: ref_6
  article-title: Transmissibility of 1918 pandemic influenza
  publication-title: Nature
  doi: 10.1038/nature03063
– volume: 84
  start-page: 2691
  year: 2003
  ident: ref_83
  article-title: Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.19277-0
– volume: 337
  start-page: 199
  year: 2012
  ident: ref_11
  article-title: An overlapping protein-coding region in influenza A virus segment 3 modulates the host response
  publication-title: Science
  doi: 10.1126/science.1222213
– volume: 356
  start-page: 1861
  year: 2001
  ident: ref_3
  article-title: The evolution of human influenza viruses
  publication-title: Philos. Trans. R. Soc. Lond. B. Biol. Sci.
  doi: 10.1098/rstb.2001.0999
– volume: 88
  start-page: 530
  year: 2007
  ident: ref_57
  article-title: Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.82120-0
– volume: 5
  start-page: 2424
  year: 2013
  ident: ref_29
  article-title: Transport of the Influenza virus genome from nucleus to nucleus
  publication-title: Viruses
  doi: 10.3390/v5102424
– volume: 381
  start-page: 1916
  year: 2013
  ident: ref_92
  article-title: Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(13)60903-4
– volume: 8
  start-page: 741
  year: 2017
  ident: ref_80
  article-title: Characterization of novel reassortant influenza A (H5N2) viruses isolated from poultry in Eastern China, 2015
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2017.00741
– volume: 48
  start-page: 33
  year: 2017
  ident: ref_79
  article-title: Infectivity, transmission and pathogenicity of H5 highly pathogenic avian influenza clade 2.3.4.4 (H5N8 and H5N2) United States index viruses in Pekin ducks and Chinese geese
  publication-title: Vet. Res.
  doi: 10.1186/s13567-017-0435-4
– reference: 23049973 - PLoS One. 2012;7(9):e46183
– reference: 9814710 - Cell. 1998 Oct 30;95(3):409-17
– reference: 10774473 - Annu Rev Med. 2000;51:407-21
– reference: 24130481 - PLoS Pathog. 2013;9(10):e1003657
– reference: 19618626 - Rev Sci Tech. 2009 Apr;28(1):187-202
– reference: 19995968 - Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21312-6
– reference: 24104053 - Viruses. 2013 Oct 02;5(10):2424-46
– reference: 22302878 - J Gen Virol. 2012 May;93(Pt 5):987-97
– reference: 27033724 - Sci Rep. 2016 Apr 01;6:23746
– reference: 19471865 - Sci China C Life Sci. 2009 May;52(5):428-38
– reference: 26872862 - Antiviral Res. 2016 May;129:21-38
– reference: 15163510 - Virus Res. 2004 Jul;103(1-2):199-203
– reference: 24009358 - Science. 2013 Oct 11;342(6155):243-7
– reference: 23805130 - Front Microbiol. 2013 Jun 26;4:151
– reference: 2024485 - Virology. 1991 Jun;182(2):475-85
– reference: 28609260 - Emerg Infect Dis. 2017 Aug;23 (8):1368-1371
– reference: 19474418 - N Engl J Med. 2009 Jul 9;361(2):115-9
– reference: 17719149 - Vaccine. 2007 Sep 28;25(39-40):6852-62
– reference: 20542248 - Cell Host Microbe. 2010 Jun 25;7(6):440-51
– reference: 19423869 - N Engl J Med. 2009 Jun 18;360(25):2605-15
– reference: 28169827 - Emerg Infect Dis. 2017 Apr;23 (4):637-641
– reference: 25186370 - BMC Infect Dis. 2014 Sep 04;14:480
– reference: 27629812 - Sci Rep. 2016 Sep 15;6:33334
– reference: 17913310 - Vaccine. 2007 Nov 1;25(44):7656-63
– reference: 7326745 - Cell. 1981 Nov;26(3 Pt 1):391-400
– reference: 19786538 - J Immunol. 2009 Oct 15;183(8):5180-9
– reference: 10872718 - Biomed Pharmacother. 2000 May;54(4):196-209
– reference: 23787694 - Nature. 2013 Jul 25;499(7459):496-9
– reference: 10872717 - Biomed Pharmacother. 2000 May;54(4):188-95
– reference: 27875109 - Emerg Infect Dis. 2017 Feb;23 (2):359-360
– reference: 12016304 - Science. 2002 May 17;296(5571):1270-3
– reference: 28617868 - PLoS Pathog. 2017 Jun 15;13(6):e1006390
– reference: 16682242 - Microbes Infect. 2006 Apr;8(5):1287-93
– reference: 22090127 - J Virol. 2012 Feb;86(3):1750-7
– reference: 20700447 - PLoS Pathog. 2010 Aug 05;6(8):e1001034
– reference: 24655395 - Emerg Infect Dis. 2014 Apr;20(4):542-51
– reference: 12917448 - J Gen Virol. 2003 Sep;84(Pt 9):2285-92
– reference: 24391501 - PLoS Pathog. 2014 Jan;10 (1):e1003845
– reference: 11576290 - J Appl Microbiol. 2001 Oct;91(4):572-9
– reference: 15200862 - Emerg Infect Dis. 2004 Apr;10(4):693-9
– reference: 24856098 - Emerg Infect Dis. 2014 Jun;20(6):1087-9
– reference: 24891213 - Ann N Y Acad Sci. 2014 Sep;1323:115-39
– reference: 19565018 - J Mol Genet Med. 2008 Nov 27;3(1):158-66
– reference: 16945980 - Mol Biol Evol. 2006 Dec;23(12):2336-41
– reference: 18721995 - Virology. 2008 Oct 10;380(1):12-20
– reference: 23623390 - Lancet. 2013 Jun 1;381(9881):1916-25
– reference: 24762827 - Nat Rev Immunol. 2014 May;14(5):315-28
– reference: 28458567 - Infect Drug Resist. 2017 Apr 20;10 :121-134
– reference: 28487690 - Front Microbiol. 2017 Apr 25;8:741
– reference: 22745253 - Science. 2012 Jul 13;337(6091):199-204
– reference: 21083388 - N Engl J Med. 2010 Nov 18;363(21):2036-44
– reference: 13679603 - J Gen Virol. 2003 Oct;84(Pt 10):2691-703
– reference: 26778522 - Int J Infect Dis. 2016 Feb;43:85-9
– reference: 26667656 - Wiley Interdiscip Rev RNA. 2016 Jan-Feb;7(1):129-43
– reference: 20591210 - Anim Health Res Rev. 2010 Jun;11(1):3-18
– reference: 23824818 - J Virol. 2013 Sep;87(17):9911-22
– reference: 19820273 - Postgrad Med. 2009 Sep;121(5):43-7
– reference: 25762140 - Nature. 2015 Jun 4;522(7554):102-5
– reference: 18418375 - Nature. 2008 May 29;453(7195):615-9
– reference: 15602562 - Nature. 2004 Dec 16;432(7019):904-6
– reference: 28259506 - J Formos Med Assoc. 2017 Mar;116(3):210-212
– reference: 24507376 - Lancet. 2014 Feb 22;383(9918):714-21
– reference: 26206138 - Protein Cell. 2015 Oct;6(10):712-21
– reference: 23641058 - Science. 2013 Jun 21;340(6139):1463-7
– reference: 28539661 - Sci Rep. 2017 May 24;7(1):2352
– reference: 27714494 - J Comput Aided Mol Des. 2016 Oct;30(10 ):917-926
– reference: 24555472 - Annu Rev Immunol. 2014;32:513-45
– reference: 24024871 - Expert Rev Vaccines. 2013 Sep;12(9):1085-94
– reference: 19840674 - Vaccine. 2009 Oct 23;27(45):6363-5
– reference: 27097026 - PLoS Pathog. 2016 Apr 20;12(4):e1005583
– reference: 17139286 - Nat Rev Drug Discov. 2006 Dec;5(12):1015-25
– reference: 26792744 - J Virol. 2016 Jan 20;90(7):3794-9
– reference: 19828614 - J Virol. 2010 Jan;84(1):558-64
– reference: 11779385 - Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1861-70
– reference: 24460592 - Vet Res. 2014 Jan 25;45:7
– reference: 20852645 - Nat Struct Mol Biol. 2010 Oct;17(10):1266-8
– reference: 1579108 - Microbiol Rev. 1992 Mar;56(1):152-79
– reference: 28592320 - Vet Res. 2017 Jun 7;48(1):33
– reference: 25654614 - MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):111
– reference: 17081640 - Virus Res. 2007 Mar;124(1-2):12-21
– reference: 26537686 - J Virol. 2015 Nov 04;90(2):1009-22
– reference: 7815489 - J Virol. 1995 Feb;69(2):1099-106
– reference: 17251571 - J Gen Virol. 2007 Feb;88(Pt 2):530-5
– reference: 11779383 - Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1845-55
– reference: 8438586 - Virology. 1993 Mar;193(1):503-6
– reference: 27279280 - Sci Rep. 2016 Jun 09;6:26787
– reference: 24990620 - Curr Top Microbiol Immunol. 2014;385:359-75
– reference: 19004788 - Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41
– reference: 17692139 - Anim Health Res Rev. 2007 Jun;8(1):1-21
– reference: 24162312 - Sci Rep. 2013 Oct 28;3:3058
– reference: 21791661 - J Infect Dis. 2011 Aug 15;204(4):592-600
– reference: 26490959 - Nucleic Acids Res. 2015 Dec 2;43(21):10321-37
– reference: 28262734 - Sci Rep. 2017 Mar 06;7:43566
– reference: 24668228 - EMBO J. 2014 Apr 16;33(8):823-41
– reference: 8091680 - Virology. 1994 Oct;204(1):462-5
– reference: 21632115 - J Infect. 2011 Oct;63(4):252-9
– reference: 23577628 - N Engl J Med. 2013 May 16;368(20):1888-97
– reference: 23170167 - Viruses. 2012 Sep;4(9):1438-76
– reference: 24829357 - J Virol. 2014 Aug;88(15):8375-85
– reference: 27424943 - Clin Microbiol Infect. 2016 Dec;22(12 ):975-983
– reference: 14643124 - Lancet. 2003 Nov 22;362(9397):1733-45
– reference: 16586359 - J Infect Dis. 2006 May 1;193(9):1229-35
– reference: 28533172 - Eur J Pharmacol. 2017 Aug 15;809:178-190
– reference: 21747392 - Nat Rev Microbiol. 2011 Jul 11;9(8):590-603
– reference: 28583578 - Lancet Infect Dis. 2017 Aug;17 (8):822-832
SSID ssj0023259
Score 2.6075315
SecondaryResourceType review_article
Snippet Influenza A virus (IAV), a highly infectious respiratory pathogen, has continued to be a significant threat to global public health. To complete their life...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1650
SubjectTerms Animals
Evolution, Molecular
Genome, Viral
Genomes
Host-Pathogen Interactions
Humans
Influenza
Influenza A virus - classification
Influenza A virus - genetics
Influenza, Human - epidemiology
Influenza, Human - virology
Mutation
Orthomyxoviridae Infections - epidemiology
Orthomyxoviridae Infections - virology
Pathogens
Reassortant Viruses - genetics
Review
Virus Replication
Viruses
SummonAdditionalLinks – databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3faxQxEB60UvClqP3h6ikR2icJ3Wyymw0IckjPKrQPpZW-LUkuS090r70fQv3rndnNrVdLfc7A7s4kmW-S2e8D2A8-wyXkU26s8Jyu1niJeYr7PNPCizKSVZ-cFscX6utlfhkP3OaxrXK1J7Yb9Xjq6Yz8EIGGKZUyhf54fcNJNYpuV6OExmN4IjDTUEtXOfrcF1wya8XSBOYgXuSm6BrfJZb5h5PvP-eiVZ2gP-7XU9I9nPlvu-Ra_hk9g60IHNmwi_RzeBSaF7DZSUnebsOHo19xErFpzb500iO_LRuyb5PZcs7cLTtZdtfuzDZjdhY4RWbWNpnvwMXo6PzTMY_KCNwrXS54LRGoZSa3hQ7O5wUWSXU-Vo64472SYWwR9gSD5ZwKrk7T2gdplEmd8UIHI-QubDTTJrwE5rFkkhbrHhmc8iK1wmltFQIbj94OLoH3K-dUPtKGk3rFjwrLB3Jlte7KBA566-uOLuMBu8HKz1VcNPPqb4gTeNcP43SnOwzbhOmSbLLClET0lsBeF5b-QfglpUT8k4C-E7DegKi07440k6uWUjvPiYgpffX_13oNTzPK6tQxogewsZgtwxvEJAv3tp14fwAAQ97m
  priority: 102
  providerName: ProQuest
Title Evolution of Influenza A Virus by Mutation and Re-Assortment
URI https://www.ncbi.nlm.nih.gov/pubmed/28783091
https://www.proquest.com/docview/1939844967
https://www.proquest.com/docview/1926980214
https://pubmed.ncbi.nlm.nih.gov/PMC5578040
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1daxQxFL3UFsEXsfWjY9slgj7J6GQmmUzAUqrstgpbpLiyb0OSzdAtddbuh7j-eu_d-aDb1hdf5mUSAvcm3HO4l3MAXnsX4xNyUagNdyG11sIM61ToZKy441ktVt0_S08H4stQDjegcRutAzi7l9qRn9RgevXu9_XyCB_8ITFOpOzvx5c_ZnzlIEHkfQtrkiIvg75o-wkIG6Suxt7v7CA54ExlSaT5em26Azhvz03eKES9J_C4RpDsuEr5Nmz4cgceVp6Sy6fwofurvk1sUrDPlQfJH8OO2ffxdDFjdsn6i6r_zkw5Yuc-pBRNV9Pmz2DQ6377dBrWFgmhEyqbh0WCiC3W0qTKWydTZEuFHAlLIvJOJH5kEP94jbxOeFtEUeF8ooWOrHZcec2T57BZTkq_C8xhFBKDBCjxVjgeGW6VMgIRjhNCexvA2yY4uav1w8nG4ipHHkFRzW9GNYA37eqflW7GP9btN3HOm-TnCCp1hoemKoBX7W-899TMMKWfLGhNnOqMFN8CeFGlpT2oyWcAai1h7QLS1F7_U44vVtraUpIiU_Tyv3fuwaOYKj9Nlah92JxPF_4AccvcduCBGir8Zr2TDmx97J59Pe9QJZGd1WX9C2wt8S0
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgSXijcpBYxET8hqEjtxLIGqCrrs0m4PqEW9pbbXEYsgW_YBWn4Uv7EzebEFwa3njPKYGXu-yYy_AXjhXYxLyIVcm8hxKq3xDOMUd0msIhdlDVn18Cjtn8j3p8npGvxqz8JQW2W7J1Yb9Wji6B_5DgINnUmpU7V7_o3T1CiqrrYjNGq3OPDLH5iyzV4P3qJ9t-O4t3_8ps-bqQLcSZXNeSEQ5MQ6Many1iUpJhhFMpKWeNedFH5kEDJ4jamQ9LYIw8J5oaUOrXaR8joSeN9rcF0KjOR0Mr33rkvwRFwNZ4sw5vE00WndaI-C4c7489dZVE25oBP-qyHwL1z7Z3vmSrzr3YaNBqiyvdqz7sCaL-_CjXp05fIevNr_3jgtmxRsUI86-WnYHvs4ni5mzC7ZcFGX-ZkpR-yD5-QJ06qp_T6cXInOHsB6OSn9I2AOUzRhMM8S3koXhSayShmJQMqhdb0N4GWrnNw1NOU0LeNLjukKqTJfVWUA2530eU3P8Q-5rVbPebNIZ_lvlwrgeXcZlxfVTEzpJwuSiVOdEbFcAA9rs3QPwi_JBOKtANQlg3UCRN19-Uo5_lRReCcJET-Fm_9_rWdws388PMwPB0cHj-FWTIiCulXUFqzPpwv_BPHQ3D6tnJDB2VV7_QXSLxrx
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUC9VLybUsBI9ISsjWMnjiUQKnRXXUpXVUVRb8H2OupWkC37AC0_jV_HOC-2ILj1nFEeM2PPN5nxNwDPnY1wCdmQKs0s9aU1mmKcojaOJLMsrcmqj4bJwal4dxafrcHP5iyMb6ts9sRyox5NrP9H3kWgoVIhVCK7ed0Wcbzff335lfoJUr7S2ozTqFzk0C2_Y_o2ezXYR1vvRlG_9-HtAa0nDFArZDqnOUfAE6lYJ9IZGyeYbOTxSBjPwW4FdyON8MEpTIuEM3kY5tZxJVRolGXSKcbxvjdgXfqsqAPrb3rD45M23eNROaqNYQSkSaySqu2ecxV2xxdfZqyceeHP-68GxL9Q7p_NmivRr38bNmvYSvYqP7sDa664CzerQZbLe_Cy9612YTLJyaAafPJDkz3ycTxdzIhZkqNFVfQnuhiRE0e9X0zLFvf7cHotWnsAnWJSuC0gFhM2rjHr4s4Iy0LNjJRaIKyyaGtnAnjRKCezNWm5n53xOcPkxasyW1VlALut9GVF1vEPuZ1Gz1m9ZGfZbwcL4Fl7GRebr6Dowk0WXiZKVOpp5gJ4WJmlfRB-ScoRfQUgrxisFfBE3levFOPzktA7jj0NVLj9_9d6CrfQ47P3g-HhI9iIPLzwrStyBzrz6cI9RnA0N09qLyTw6bod_xevnyCD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evolution+of+Influenza+A+Virus+by+Mutation+and+Re-Assortment&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Shao%2C+Wenhan&rft.au=Li%2C+Xinxin&rft.au=Goraya%2C+Mohsan+Ullah&rft.au=Wang%2C+Song&rft.date=2017-08-07&rft.pub=MDPI&rft.eissn=1422-0067&rft.volume=18&rft.issue=8&rft_id=info:doi/10.3390%2Fijms18081650&rft_id=info%3Apmid%2F28783091&rft.externalDocID=PMC5578040
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon